Additional European Equity News

AstraZeneca (AZN LN) - Baxdrostat met the primary endpoint in Bax24 Phase 3 trial in   patients with resistant hypertension. (Astrazeneca)  

B&M (BME LN) - H1 (GBP): Revenue grows 4.0% to 2.75bln, UK LFL sales grew 0.1%, expects Adj. EBITDA of 198mln, FY26 Adj. EBITDA of 510-560mln. (B&M) 

Bayer (BAYN GY) - BlueRock Therapeutics reports positive 36-month results for Phase 1 trial of Demdaneprocel for treatment of Parkinson’s disease. (Bayer)

Credit Agricole (ACA FP) - Credit Agricole has postponed a 10yr CAD-bond sale following the unexpected resignation of France’s PM Lecornu, which triggered a broad selloff in French assets and pushed benchmark 10yr yields up. The bank will monitor market conditions before proceeding. (Newswires)

Getlink (GET FP) - Sept Passenger traffic -3% Y/Y. (Newswires) 

Imperial Brands (IMB LN) - Trading Update: Announced a GBP 1.45bln share buyback. FY Trading is in line with guidance which has been underpinned by growth in tobacco and NGP. FY Group Adj. Op. Profit Growth exp. to be similar rate to last year, in-line with guidance. On future of factory in Langenhagen, Germany, says, have started consultations and outcome will either be sale or closure. (Imperial Brands)

Londonmetric (LMP LN) - Expects H1 net rental income at GBP 219mln, increases Q1 dividend to 3.05p (prev. 2.85p). (Londonmetric) 

Lufthansa (LHA GY) - Co. announced an expansion of joint venture with Singapore Airlines, adds Brussels Airlines. (Lufthansa) 

Mercedes-Benz (MBG GY) - Mercedes-Benz has revamped its EV strategy with the launch of an entry-level CLA, targeting a key price segment and aiming to compete directly with BMW (MBG GY) and Tesla (TSLA), as part of the company’s broader push to strengthen its position in the global electric vehicle market, DigiTimes notes. (DigiTimes)

Metlen Energy & Metals (MTLN LN) - Hedge fund Millennium has built a GBP 35mln short position in Metlen (equivalent to 0.6% of the co's share capital), according to The Times citing a FCA filing. (The Times)

Novo Nordisk (NOVOB DC) - Novo-backed MapLight Therapeutics, a biotech firm developing neurological disorder treatments, plans to raise USD 251mln via a US IPO and private placement despite the government shutdown. The Redwood City-based company is offering 14.8mln shares at USD 17 each, with Goldman Sachs-managed funds expected to buy 476,707 shares in a private placement. (Newswires)

Naturgy (NTGY SM) - Announcement placement of around EUR 883.19mln, priced at EUR 25.90/shr; representing approx. 3.5% of share capital. To hold around 9.12mln treasury shares, reducing to 0.94%. Settlement of placement is exp. around Oct. 9 2025. (Newswires) 

Orsted (ORSTED DC) - CEO says "we still plan to finish the Sunrise wind project in the US in H2'27". Will communicate further organisation in Q4. Says have fully resumed work on Revolution Wind in the US and exp. to finish the project by H2'26. (Newswires)

Rheinmetall (RHM GY) - Australian defence industry boss hit out at the Co. for its “power and influence” in the industry. (FT)  

Shell (SHEL LN) - Outlook Q3 Chemicals and Products Trading & Optimisation is exp. to higher than in Q2'25; chemicals and products trading is also seen higher. Q3 Non-cash post tax impairments and provisions of around USD 0.6bln are exp. in marketing segment. Outlook (USD): Production (kboe/d) 910-950 (prev. 913), Upstream Production (kboe/d) 1,790-1,890 (prev. 2), Pre-tax depreciation 1.4-1.8bln (prev. 1.6bln). Note: prev. refers to Q2'25.

UK Housing - UK Halifax House Prices MM (Sep) -0.3% vs. Exp. 0.2% (Prev. 0.3%, Rev. 0.2%); YY (Sep) 1.3% (Prev. 2.20%, Rev. 2.0%). (Newswires) 

Hermes (RMS FP) downgraded to Equal Weight from Overweight at Morgan Stanley 

Kering (KER FP) upgraded to Overweight from Equal Weight at Morgan Stanley; PT raised to EUR 370 (prev. EUR 250)

LVMH (MC FP) upgraded to Overweight from Equal Weight at Morgan Stanley; PT raised to EUR 625 (prev. EUR 515) 

Redcare Pharmacy (RDC GY) initiated with Overweight at Barclays 

TomTom (TOM2 NA) upgraded to Buy from Hold at Kepler Cheuvreux 

07 Oct 2025 - 07:20- ForexEU Research- Source: Newsquawk